Search Results - "Purmal, A"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

    Synthesis of Carbazole Derivative PLX01107 and its Pharmacokinetics for Various Administration Routes in CD-1 Mice by Eremina, N. V., Kazei, V. I., Purmal, A. A., Durnev, A. D.

    Published in Pharmaceutical chemistry journal (01-05-2017)
    “…The substituted carbazole drug PLX01107 is being developed for the treatment of invasive pulmonary aspergillosis. A synthetic method for PLX01107 drug…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Multiply damaged sites in DNA: Interactions with Escherichia coli endonucleases III and VIII by Harrison, Lynn, Hatahet, Zafer, Purmal, Andrei A., Wallace, Susan S.

    Published in Nucleic acids research (15-02-1998)
    “…Bursts of free radicals produced by ionization of water in close vicinity to DNA can produce clusters of opposed DNA lesions and these are termed multiply…”
    Get full text
    Journal Article
  9. 9

    FACT inhibitor CBL0137, administered in an optimized schedule, potentiates radiation therapy for glioblastoma by suppressing DNA damage repair by Barone, Tara A, Robinson, Denisha L, Qiu, Jingxin, Gurova, Katerina V, Purmal, Andrei A, Gudkov, Andrei V, Plunkett, Robert J

    Published in Journal of neuro-oncology (09-09-2024)
    “…Standard-of-care for glioblastoma remains surgical debulking followed by temozolomide and radiation. However, many tumors become radio-resistant while…”
    Get full text
    Journal Article
  10. 10

    Enzymatic Processing of Uracil Glycol, a Major Oxidative Product of DNA Cytosine by Purmal, A A, Lampman, G W, Bond, J P, Hatahet, Z, Wallace, S S

    Published in The Journal of biological chemistry (17-04-1998)
    “…A major stable oxidation product of DNA cytosine is uracil glycol (Ug). Because of the potential of Ug to be a strong premutagenic lesion, it is important to…”
    Get full text
    Journal Article
  11. 11

    Antitumor effect of the curaxin CBL0137 on the models of colon cancer by Fetisov, T. I., Tilova, L. R., Lesovaya, E. A., Antoshina, E. E., Gor’kova, T. G., Trukhanova, L. S., Morozova, O. V., Shipaeva, E. V., Ivanov, R. V., Purmal, A. A., Belitskiy, G. A., Yakubovskaya, M. G., Gudkov, A. V., Gurova, K. V., Kirsanov, K. I.

    Published in Uspehi molekulârnoj onkologii (01-09-2016)
    “…Curaxins represent low molecular weight carbazole derivatives, which simultaneously activate p53-dependent apoptosis and inhibit NF-kBdependent signal…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Major oxidative products of cytosine, 5-hydroxycytosine and 5-hydroxyuracil, exhibit sequence context-dependent mispairing in vitro by Purmal, Andrei A., Kow, Yoke Wah, Wallace, Susan S.

    Published in Nucleic acids research (11-01-1994)
    “…Two major stable oxidation products of 2′-deoxy-cytidine are 2′-deoxy-5-hydroxycytldine (5-OHdC) and 2′-deoxy-5-hydroxyuridine (5-OHdU). In order to study the…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Process for the preparation of pathogen-inactivated RBC concentrates by using PEN110 chemistry: preclinical studies by Purmal, Andrei, Valeri, C. Robert, Dzik, Walter, Pivacek, Linda, Ragno, Gina, Lazo, Aris, Chapman, John

    Published in Transfusion (Philadelphia, Pa.) (01-02-2002)
    “…BACKGROUND: A pathogen‐inactivation process for RBC concentrates is being developed by using PEN110 chemistry (INACTINE, V.I. Technologies). The objective of…”
    Get full text
    Journal Article
  17. 17

    alpha.-Deoxyadenosine, a Major Anoxic Radiolysis Product of Adenine in DNA, Is a Substrate for Escherichia coli Endonuclease IV by Ide, Hiroshi, Tedzuka, Kei, Shimzu, Hironori, Kimura, Yoshiharu, Purmal, Andrei A, Wallace, S. S, Kow, Y. W

    Published in Biochemistry (Easton) (28-06-1994)
    “…Oligonucleotides containing a unique alpha-deoxyadenosine or tetrahydrofuran (a model abasic site) were synthesized using phosphoramidite chemistry. Repair…”
    Get full text
    Journal Article
  18. 18

    Preclinical Validation of a Single-Treatment Infusion Modality That Can Eradicate Extremity Melanomas by Kim, Minhyung, Neznanov, Nickolay, Wilfong, Chandler D, Fleyshman, Daria I, Purmal, Andrei A, Haderski, Gary, Stanhope-Baker, Patricia, Burkhart, Catherine A, Gurova, Katerina V, Gudkov, Andrei V, Skitzki, Joseph J

    Published in Cancer research (Chicago, Ill.) (15-11-2016)
    “…Isolated limb perfusion (ILP) with the chemotherapeutic agent melphalan is an effective treatment option for extremity in-transit melanoma but is toxic and…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Inactivation of Gram-negative and Gram-positive bacteria in red cell concentrates using INACTINE PEN110 chemistry by Zavizion, B., Serebryanik, D., Chapman, J., Alford, B., Purmal, A.

    Published in Vox sanguinis (01-10-2004)
    “…Background and Objectives  The risk of transfusion‐transmitted bacterial infections as a result of the presence of bacteria in blood is one of the major…”
    Get full text
    Journal Article